Health Care & Life Sciences » Pharmaceuticals | Novartis India Ltd.

Novartis India Ltd. | Income Statement

Fiscal year is April-March. All values INR Millions.
2014
2015
2016
2017
2018
Sales/Revenue
8,369
8,424
6,898
6,562
5,639
Cost of Goods Sold (COGS) incl. D&A
6,648
6,462
5,080
4,945
4,330
Gross Income
1,721
1,962
1,818
1,618
1,309
SG&A Expense
1,926
2,235
1,409
1,277
1,287
EBIT
239
345
-
-
45
Unusual Expense
12
21
2
1
-
Non Operating Income/Expense
331
514
52
40
152
Interest Expense
3
-
-
-
-
Pretax Income
912
945
1,130
917
1,575
Income Tax
73
154
406
345
792
Consolidated Net Income
985
791
725
572
784
Net Income
985
791
725
572
784
Net Income After Extraordinaries
985
742
533
572
784
Net Income Available to Common
985
791
1,983
572
784
EPS (Basic)
30.83
26.28
62.04
19.10
28.43
Basic Shares Outstanding
32
32
32
30
28
EPS (Diluted)
30.83
26.28
62.04
19.10
28.43
Diluted Shares Outstanding
32
32
32
30
28
EBITDA
203
305
388
285
19
Other Operating Expense
34
72
55
91
67
Non-Operating Interest Income
811
797
723
627
1,468

About Novartis India

View Profile
Address
Sandoz House, Shivsagar Estate
Mumbai Maharashtra 400018
India
Employees -
Website http://www.novartis.in
Updated 09/14/2018
Novartis India Ltd. engages in the research, development, and commercialization of pharmaceutical products. Its products include alcon, and sandoz. The company was founded on December 13, 1947 and is headquartered in Mumbai, India.